CMS’s preliminary 2027 CLFS rate data confirms significant downward pressure on lab reimbursement — molecular and genomic labs face the largest projected reductions, and the public comment window closes October 21.
CMS’s preliminary 2027 CLFS rate data confirms significant downward pressure on lab reimbursement — molecular and genomic labs face the largest projected reductions, and the public comment window closes October 21.